• Aucun résultat trouvé

18 résultats avec le mot-clé: 'smad hepatitis c virus cell entry liver disease'

SMAD About Hepatitis C Virus Cell Entry and Liver Disease

Infection of hepatocytes with HCV increases cell surface levels of heparan sulfate proteoglycans, uptake of cholesterol and lipoprotein, and virus entry by up- regulating SMAD6

Protected

N/A

6
0
0
2021
structure de pile

Chaînes bien parenthésées Calculatrice en polonaise inversée Percolation. 1 La structure

Protected

N/A

45
0
0
2022
aucun  n'avait  de  symptôme  oculaire  mais  3  sur  6  avaient  un  tarissement  sécrétoire  lacrymal  objectivé  par  le  test  de  Schirmer.  Le  mécanisme  de  l'infll­

Lymphocytic sialadenitis of Sjôgren's syndrome associated with chronic hepatitis C virus liver

Protected

N/A

1
0
0
2021
Hepatitis C virus entry.

Given the essential role of host cell surface entry factors in HCV cell-to-cell transmission and thus for spread and maintenance of infection, it is not

Protected

N/A

42
0
0
2021
HEPATITE VIRALE G

Hepatitis C virus genotypes and co-infection with GB virus C in patients with anti- HCV-positive chronic liver disease in Jakarta, Indonesia. Int

Protected

N/A

163
0
0
2021
Awareness of the severity of liver disease re-examined using software-combined biomarkers of liver fibrosis and necroinflammatory activity

Objective: To compare the awareness of liver disease severity between the USA and France, two countries with similar access to hepatitis C virus (HCV) and hepatitis B virus

Protected

N/A

12
0
0
2021
The lady with nephrotic-range proteinuria and necroses after exposure to cold

Lymphocytic sialaden- itis of Sjogren's syndrome associated with chronic hepatitis C virus liver disease.. Pascual M, Perrin L, Giostra E,

Protected

N/A

2
0
0
2021
A genome-wide gain-of-function screen identifies CDKN2C as a HBV host factor

CDKN2C levels were markedly elevated in the tumor liver tissue of patients chronically infected with hepatitis C virus (HCV) or HBV and patients with alcoholic liver disease (ALD)

Protected

N/A

18
0
0
2021
Identification of Novel Functions for Hepatitis C Virus Envelope Glycoprotein E1 in Virus Entry and Assembly

Keywords: hepatitis C virus; glycoprotein; envelope proteins; viral entry; viral assembly

Protected

N/A

49
0
0
2021
Cholesterol uptake and hepatitis C virus entry.

HCV: Hepatitis C virus; FDA: US Food and Drug Administration; NPC1L1: Niemann-Pick C1-like 1; HCVcc: cell culture-derived HCV; HCVpp: HCV pseudoparticles; GAG:

Protected

N/A

9
0
0
2021
publication

Abbreviations: AH, alcoholic hepatitis; ALD, alcoholic liver disease; ASH, alcoholic steatohepatitis; ACLF, acute on chronic liver failure; LPC, liver progenitor cell; K7,

Protected

N/A

13
0
0
2022
Liver transplantation for hepatocellular carcinoma after successful treatment of macrovascular invasion

HCV, hepatitis C; HBV, hepatitis B; HCC, hepatocellular carcinoma; MELD, model for end-stage liver disease; LT, liver transplantation; MVI, macrovascular invasion; AFP

Protected

N/A

22
0
0
2022
Liver pathology in rural south-west Cameroon

Hepatitis C virus infection seems to play an important role in the development of chronic liver pathology; 40% of cirrhotic patients had a combined hepatitis B and C virus

Protected

N/A

4
0
0
2021
Claudin-1, miR-122 and apolipoprotein E transductions improve the permissivity of SNU-182, SNU-398 and SNU-449 hepatoma cells to hepatitis C virus

different hepatoma cell lines to cell culture adapted hepatitis C virus. Characterization of cell lines established from

Protected

N/A

25
0
0
2021
Influence of hepatitis G virus infection on liver disease

Hepatitis G virus was detected in 18% of patients with chronic hepatitis C, 13% of patients with al- coholic liver cirrhosis, 11% of patients with primary

Protected

N/A

4
0
0
2021
Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies.

Scavenger receptor BI is a key host factor for Hepatitis C virus infection required for an

Protected

N/A

41
0
0
2021
Hepatitis C virus entry and cell-cell transmission : implication for viral life cycle and antiviral treatment

In the past couple of years, we have discovered epidermal growth factor receptor (EGFR) and Ephrin receptor A2 (EphA2) as novel HCV entry factors and developed a series

Protected

N/A

170
0
0
2021
Theaflavins, polyphenols of black tea, inhibit entry of hepatitis C virus in cell culture

As shown in Fig 5, the inhibitory effect of theaflavins on pre-incubated virus is similar to the one observed when virus is inoculated on cells at high concentration (25

Protected

N/A

17
0
0
2021

Télécharger plus de documents et télécharger des études de documentation immédiatement !